23:23 , Oct 19, 2018 |  BioCentury  |  Finance

CuraSen’s SPARK

After debuting with a $54.5 million series A round, CuraSen Therapeutics Inc. hopes to generate clinical proof-of-concept data for at least two neurodegenerative disease programs in the next three years. New Leaf Venture Partners led...
18:00 , Oct 19, 2018 |  BC Week In Review  |  Financial News

Led by ex-Afferent execs, CuraSen raises $54.5M series A

Neurodegenerative disease company CuraSen Therapeutics Inc. (San Mateo, Calif.) raised $54.5 million in a series A round on Oct. 17 led by New Leaf Venture Partners. Also participating were Longitude Capital, funds managed by Tekla...
18:23 , Oct 17, 2018 |  BC Extra  |  Financial News

Led by ex-Afferent execs, CuraSen raises $54.5M series A

Neurodegenerative disease company CuraSen Therapeutics Inc. (San Mateo, Calif.) raised $54.5 million in a series A round led by New Leaf Venture Partners. Also participating were Longitude Capital, funds managed by Tekla Capital, Alta Partners,...
18:46 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Sutro proposes $75M IPO

Sutro Biopharma Inc. (South San Francisco, Calif.) proposed on Aug. 29 to raise $75 million in an IPO on NASDAQ underwritten by Cowen, Piper Jaffray, JMP Securities and Wedbush PacGrow. Concurrent with the proposed IPO,...
22:51 , Aug 29, 2018 |  BC Extra  |  Financial News

Sutro proposes $75M IPO

Sutro Biopharma Inc. (South San Francisco, Calif.) proposed on Wednesday to raise $75 million in an IPO on NASDAQ underwritten by Cowen, Piper Jaffray, JMP Securities and Wedbush PacGrow. Concurrent with the proposed IPO, Merck...
17:00 , Jul 27, 2018 |  BC Week In Review  |  Financial News

Sutro raises $85.4M series E

Sutro Biopharma Inc. (South San Francisco, Calif.) raised $85.4 million on July 26 in an untranched series E round led by new investors Samsara BioCapital and Surveyor Capital. Also participating in the round were existing...
16:45 , Jul 27, 2018 |  BC Week In Review  |  Financial News

Chinese xenotransplantation company Qihan grabs $7.8M series A

Hangzhou Qihan Bio Inc. (Hangzhou, China) raised $7.8 million on July 23 in a series A round led by Sequoia Capital China. Arch Venture Partners, Northern Light Venture Capital, Biomatics Capital and Alta Partners also...
23:40 , Jul 26, 2018 |  BC Extra  |  Financial News

Sutro raises $85.4M series E

Sutro Biopharma Inc. (South San Francisco, Calif.) raised $85.4 million in an untranched series E round led by new investors Samsara BioCapital and Surveyor Capital. Also participating in the round were existing investors Alta Partners,...
17:12 , Jul 20, 2018 |  BC Week In Review  |  Financial News

Allakos spikes after pricing upsized IPO above range

Allakos Inc. (NASDAQ:ALLK) gained $13.25 (74%) to $31.25 July 19 after it raised $128.4 million through the sale of 7.1 million shares at $18 in an upsized IPO. Goldman Sachs, Jefferies and William Blair are...
14:27 , Jul 19, 2018 |  BC Extra  |  Financial News

Allakos spikes after pricing upsized IPO above range

Allakos Inc. (NASDAQ:ALLK) gained $13.25 (74%) to $31.25 Thursday after it raised $128.4 million through the sale of 7.1 million shares at $18 in an upsized IPO. Goldman Sachs, Jefferies and William Blair are underwriters....